BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16476875)

  • 1. Adherence to black box warnings for prescription medications in outpatients.
    Lasser KE; Seger DL; Yu DT; Karson AS; Fiskio JM; Seger AC; Shah NR; Gandhi TK; Rothschild JM; Bates DW
    Arch Intern Med; 2006 Feb; 166(3):338-44. PubMed ID: 16476875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescriber compliance with black box warnings in older adult patients.
    Ricci JR; Coulen C; Berger JE; Moore MC; McQueen A; Jan SA
    Am J Manag Care; 2009 Nov; 15(11):e103-8. PubMed ID: 19895180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA drug prescribing warnings: is the black box half empty or half full?
    Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records.
    Buck MD; Atreja A; Brunker CP; Jain A; Suh TT; Palmer RM; Dorr DA; Harris CM; Wilcox AB
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):84-92. PubMed ID: 19447361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of implementing alerts about medication black-box warnings in electronic health records.
    Yu DT; Seger DL; Lasser KE; Karson AS; Fiskio JM; Seger AC; Bates DW
    Pharmacoepidemiol Drug Saf; 2011 Feb; 20(2):192-202. PubMed ID: 21254291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug events in ambulatory care.
    Gandhi TK; Weingart SN; Borus J; Seger AC; Peterson J; Burdick E; Seger DL; Shu K; Federico F; Leape LL; Bates DW
    N Engl J Med; 2003 Apr; 348(16):1556-64. PubMed ID: 12700376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the value of electronic prescribing in ambulatory care: a focus group study.
    Weingart SN; Massagli M; Cyrulik A; Isaac T; Morway L; Sands DZ; Weissman JS
    Int J Med Inform; 2009 Sep; 78(9):571-8. PubMed ID: 19395307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overrides of medication alerts in ambulatory care.
    Isaac T; Weissman JS; Davis RB; Massagli M; Cyrulik A; Sands DZ; Weingart SN
    Arch Intern Med; 2009 Feb; 169(3):305-11. PubMed ID: 19204222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of potentially inappropriate prescribing among ambulatory older patients in the year 2001: comparison of three explicit criteria.
    Viswanathan H; Bharmal M; Thomas J
    Clin Ther; 2005 Jan; 27(1):88-99. PubMed ID: 15763610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey.
    Devine JW; Farley JF; Hadsall RS
    Headache; 2005 Oct; 45(9):1171-80. PubMed ID: 16178947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.